Early in 2020, the media covered the start of New Zealand trials of a new non-invasive bowel cancer detection system. A SIFT-MS unit was used to conduct the analysis and we at Syft Technologies thought you might be interested to read our media release – click here.

The New Zealand trials are a collaboration between Syft, Imperial College London, the University of Otago’s Wellington School of Medicine and Callaghan Innovation.

We’re thrilled to be leveraging the great relationship that we have with Professor George Hanna, the Head of Department of Surgery and Cancer at Imperial College London, together with our revolutionary SIFT-MS technology, for research that aims to deliver much earlier detection and improved diagnostic outcomes for those suffering from bowel and other gastrointestinal cancers.